Possibilities of the combined use of non-steroidal anti-inflammatory drugs and sulfhydryl compounds in radioprotection
Language English Country Germany Media print
Document type Comparative Study, Journal Article
PubMed
1849667
Knihovny.cz E-resources
- MeSH
- Amifostine administration & dosage pharmacology MeSH
- Anti-Inflammatory Agents, Non-Steroidal administration & dosage pharmacology MeSH
- Time Factors MeSH
- Whole-Body Irradiation MeSH
- Cystamine administration & dosage pharmacology MeSH
- Radiation Dosage MeSH
- Diclofenac administration & dosage pharmacology MeSH
- Drug Combinations MeSH
- Hematopoiesis drug effects radiation effects MeSH
- Drug Evaluation MeSH
- Indomethacin administration & dosage pharmacology MeSH
- Mice, Inbred C57BL MeSH
- Mice, Inbred CBA MeSH
- Mice MeSH
- Radiation-Protective Agents * MeSH
- Sulfhydryl Compounds administration & dosage pharmacology MeSH
- Drug Synergism MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- Names of Substances
- Amifostine MeSH
- Anti-Inflammatory Agents, Non-Steroidal MeSH
- Cystamine MeSH
- Diclofenac MeSH
- Drug Combinations MeSH
- Indomethacin MeSH
- Radiation-Protective Agents * MeSH
- Sulfhydryl Compounds MeSH
The combined preirradiation administration of indomethacin and cystamine was found to enhance synergistically the recovery of hemopoiesis in sublethally gamma-irradiated mice. This effect can be explained by a common operation of two mechanisms of radioprotection, i.e. of an increased survival of hemopoietic stem cells due to cystamine action and of stimulatory effects of indomethacin on the proliferation of surviving cells, mediated by the inhibition of prostaglandin synthesis. Attempts to prove such enhancement of protective effects on irradiated mice in terms of postirradiation lethality were unsuccessful. The reason seems to be the influence of toxic effects of the indomethacin-cystamine combination on the gastrointestinal tract. When using the less toxic combination, i.e. diclofenac and WR-2721, the additivity of protective effects is manifested even in the survival of lethally irradiated mice. The results suggest that under suitable conditions avoiding the unfavourable toxic effects, non-steroidal anti-inflammatory drugs can be successfully used with the aim to enhance the efficiency of sulfhydryl radioprotectors.
Stimulatory action of cyclooxygenase inhibitors on hematopoiesis: a review